FDA PMA FDA Class 3 Approved 🇺🇸 United States

System, Endovascular Graft, Aortic Aneurysm Treatment

PMA: P200045 · Decision Aug 5, 2021
Classifications
1
FEI Numbers
34
Registration Numbers
34

Basic Information

Device Name
System, Endovascular Graft, Aortic Aneurysm Treatment
Trade Name
RelayPro Thoracic Stent-Graft System
PMA Number
P200045
Device Class
FDA Class 3
Product Code
MIH
Generic Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
August 5, 2021
Date Received
November 20, 2020
Expedited Review
N
Docket Number
21M-0805

Advisory Committee Statement

Approval for The Relay®Pro Thoracic Stent-Graft System. The device is indicated for the endovascular repair of fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers in the descending thoracic aorta in patients having appropriate anatomy, including:-- Iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories;-- Non-aneurysmal aortic neck diameter in the range of 20 to 42 mm; and -- Non-aneurysmal proximal aortic neck lengths of: 15 mm for the 24 to 28 mm Bare Stent Configuration device diameters 20 mm for the 30 to 38 mm Bare Stent Configuration device diameters 25 mm for the 40 to 46 mm Bare Stent Configuration device diameters 25 mm for the 24 to 38 mm Non-Bare Stent Configuration device diameters 30 mm for the 40 to 46 mm Non-Bare Stent Configuration device diameters Non-aneurysmal distal aortic neck lengths of: 25 mm for the 24 to 38 mm device diameters 30 mm for the 40 to 46 mm device diameters.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MIH System, Endovascular Graft, Aortic Aneurysm Treatment